Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideo Komita

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Immunology|July 14, 2005
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12Sadamu Homma, Hideo Komita, Yukiko Sagawa, et al.
Journal of Hepatology|August 29, 2006
Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinomaHideo Komita, Sadamu Homma, Hideo Saotome, et al.
International Journal of Cancer|June 16, 2004
Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ miceMasaki Irie, Sadamu Homma, Hideo Komita, et al.
Clinical Immunology (Orlando, Fla.)|October 26, 2005
Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12Shigeo Tamaki, Sadamu Homma, Yasuyuki Enomoto, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2007
Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparationSadamu Homma, Yukiko Sagawa, Hideo Komita, et al.
Oncology Reports|August 5, 2015
Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumorsHideo Komita, Shigeo Koido, Kazumi Hayashi, et al.
BMC Cancer|October 18, 2015
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cellsShin Kan, Shigeo Koido, Masato Okamoto, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2014
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cellsShigeo Koido, Masaki Ito, Yukiko Sagawa, et al.
Oncology Reports|May 16, 2015
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansineShin Kan, Shigeo Koido, Masato Okamoto, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 18, 2008
[Diagnosis of Helicobacter pylori infection: comparison with gold standard]Shigeo Koido, Shunichi Odahara, Makoto Mitsunaga, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Immunology|July 14, 2005
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12Sadamu Homma, Hideo Komita, Yukiko Sagawa, et al.
Journal of Hepatology|August 29, 2006
Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinomaHideo Komita, Sadamu Homma, Hideo Saotome, et al.
International Journal of Cancer|June 16, 2004
Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ miceMasaki Irie, Sadamu Homma, Hideo Komita, et al.
Clinical Immunology (Orlando, Fla.)|October 26, 2005
Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12Shigeo Tamaki, Sadamu Homma, Yasuyuki Enomoto, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2007
Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparationSadamu Homma, Yukiko Sagawa, Hideo Komita, et al.
Oncology Reports|August 5, 2015
Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumorsHideo Komita, Shigeo Koido, Kazumi Hayashi, et al.
BMC Cancer|October 18, 2015
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cellsShin Kan, Shigeo Koido, Masato Okamoto, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2014
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cellsShigeo Koido, Masaki Ito, Yukiko Sagawa, et al.
Oncology Reports|May 16, 2015
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansineShin Kan, Shigeo Koido, Masato Okamoto, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 18, 2008
[Diagnosis of Helicobacter pylori infection: comparison with gold standard]Shigeo Koido, Shunichi Odahara, Makoto Mitsunaga, et al.
Pageof 3